Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: A randomised controlled trial

Lancet

Volumn 360, Issue 9343, 2002, Pages 1375-1380

  Amadi, Beatrice ^a   Mwiya, Mwiya ^a   Musuku, John ^a   Watuka, Angela ^a   Sianongo, Sandie ^a   Ayoub, Ayman ^b   Kelly, Paul ^a,b,c  

^a UNIVERSITY OF ZAMBIA   (Zambia)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARASITIC AGENT; NITAZOXANIDE; PLACEBO;

ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DIARRHEA; DRUG EFFECT; FECES ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NONHUMAN; PARASITOLOGY; PRIORITY JOURNAL; SERODIAGNOSIS; SIDE EFFECT; TREATMENT OUTCOME; VIRUS DIAGNOSIS;

EID: 0037010366     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)11401-2     Document Type: Article

References (28)

1. Guerrant R.L. Cryptosporidiosis: an emerging, highly infectious threat. Emerg Infect Dis. 3:1997;51-57.
2. Griffiths J. Human cryptosporidiosis: epidemiology, transmission, clinical disease, treatment and diagnosis. Adv Parasitol. 40:1998;37-85.
3. Guerrant R.L., van Gilder T., Steiner T.S., et al. Practice guidelines for the management of infectious diarrhoea. Clin Infect Dis. 32:2001;331-350.
4. Mølbak K., Andersen M., Aaby P., et al. Cryptosporidium infection in infancy as a cause of malnutrition: a community study from Guinea-Bissau, West Africa. Am J Clin Nutr. 65:1997;149-152.
5. Lima A.A., Moore S.R., Barboza M.S. Jr, et al. Persistent diarrhoea signals a critical period of increased diarrhoea burdens and nutritional shortfalls: a prospective cohort study among children in northeastern Brazil. J Infect Dis. 181:2000;1643-1651.
6. Guerrant D.I., Moore S.R., Lima A.A., Patrick P.D., Schorling J.B., Guerrant R.L. Association of early childhood diarrhoea and cryptosporidiosis with impaired physical fitness and cognitive function 4-7 years later in a poor urban community in northeast Brazil. Am J Trop Med Hyg. 61:1999;707-713.
7. Mølbak K., Højlyng N., Gottschau A., et al. Cryptosporidiosis in infancy and childhood mortality in Guinea-Bissau, West Africa. BMJ. 307:1993;417-420.
8. Amadi B.C., Kelly P., Mwiya M., et al. Intestinal and systemic infection, HIV and mortality in Zambian children with persistent diarrhoea and malnutrition. J Pediatr Gastroenterol Nutr. 32:2001;550-554.
9. Blanshard C., Jackson A.M., Shanson D.C., Francis N., Gazzard B. Cryptosporidiosis in HIV seropositive patients. Q J Med. 85:1992;813-823.
10. White A.C., Chappell C.L., Hayat C.S., Kimball K.T., Flanigan T.P., Goodgame R.W. Paromomycin for cryptosporidiosis in AIDS: a prospective double blind trial. J Infect Dis. 170:1994;419-424.
11. Hewitt R.G., Yiannoutsos C.T., Higgs E.S., et al. Paromomycin: no more effective than placebo for the treatment of cryptosporidiosis in patients with advanced HIV infection. AIDS Clinical Trial Group. Clin Infect Dis. 31:2000;1084-1092.
12. Gilles H.M., Hoffman P.S. Treatment of intestinal parasitic infections: a review of nitazoxanide. Trends Parasitol. 18:2002;95-97.
13. Rossignol J.F., Ayoub A., Ayers M.S. Treatment of diarrhoea caused by Cryptosporidium parvum: a prospective randomised double-blind placebo-controlled study of nitazoxanide. J Infect Dis. 184:2001;103-106.
14. Rossignol J.F., Ayoub A., Ayers M.S. Treatment of diarrhea caused by Giardia intestinalis and Entamoeba histolytica or E. dispar: a randomized, double-blind, placebo-controlled study of nitazoxanide. J Infect Dis. 181:2001;381-384.
15. Ortiz J.J., Ayoub A., Gargala G., Chegne N.L., Favennec L. Randomized clinical study of nitazoxanide compared to metronidazole in the treatment of giardiasis in children from northern Peru. Aliment Pharmacol Ther. 15:2001;1409-1415.
16. Ortiz JJ, Chegne NL, Gargala G, Favennec L. Comparative clinical studies of nitazoxanide, albendazole and praziquantel in the treatment of ascariasis, trichuriasis and hymenolepiasis in children from Peru, Trans R Soc Trop Med Hyg (in press).
17. Theodos C.M., Griffiths J.K., D'Onfro J., Fairfield A., Tzipori S. The efficacy of nitazoxanide against Cryptosporidium parvum in cell culture and in animal models. Antimicrob Agents Chemother. 42:1998;1959-1965.
18. Gargala G., Delaunay A., Li X., Brasseur P., Favennec L., Ballet J.J. Efficacy of nitazoxanide, tizoxanide and tizoxanide glucuronide against Cryptosporidium parvum development in sporozoite-infected HCT-8 enterocytic cells. J Antimicrob Chemother. 46:2000;57-60.
19. Rossignol J.F., Hidalgo H., Feregrino M., et al. A double-blind placebo controlled study of nitazoxanide in the treatment of cryptosporidial diarrhoea in AIDS patients in Mexico. Trans R Soc Trop Med Hyg. 92:1998;663-666.
20. Soave R, Davis LW. Nitazoxanide in patients with AIDS and chronic cryptosporidial diarrhea. Clin Pharmacol Ther 2002 (in press).
21. World Medical Association. Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects as Amended by the 52nd WMA General Assembly, Edinburgh, UK, October 2000. Ferney-Voltaire, France: World Medical Association, 2000.
22. Wellcome Trust Working Party. Classification of infantile malnutrition. Lancet. 2:1970;302-303.
23. Cooperstock M., DuPont H.L., Corrado M.L., Fekety R., Murray D.M. Evaluation of new anti-infective drugs for the treatment of diarrhoea caused by Giardia lamblia. Clin Infect Dis. 15:(suppl 1):1992;S244-S248.
24. Brewster D.R., Mammary M.J., Graham S.M. Case management of kwashiorkor: an intervention project at seven nutrition rehabilitation centres in Malawi. Eur J Clin Nutr. 51:1997;139-147.
25. Phillips A.D., Thomas A.G., Walker Smith J.A. Cryptosporidium, chronic diarrhoea, and the proximal small intestinal mucosa. Gut. 33:1992;1057-1061.
26. Waterlow J.C. Protein energy malnutrition. 1992;Edward Arnold, London.
27. Solomon S.M., Kirby D.F. The refeeding syndrome: a review. J Parenteral Enteral Nutr. 14:1990;90-97.
28. Dubreuil L., Houcke X., Mouton Y., Rossignol J.F. In vitro evaluation of the activities of nitazoxanide and tizoxanide against anaerobes and aerobic organisms. Antimicrob Agents Chemother. 40:1996;2266-2270.